These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11826668)

  • 1. [Free fatty acids: mediators of insulin resistance and atherosclerosis].
    Castro Cabezas M; Erkelens DW; van Dijk H
    Ned Tijdschr Geneeskd; 2002 Jan; 146(3):103-9. PubMed ID: 11826668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPAR agonists in the treatment of insulin resistance and associated arterial disease.
    Camejo G
    Int J Clin Pract Suppl; 2003 Mar; (134):36-44. PubMed ID: 12793596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes.
    Boden G
    Exp Clin Endocrinol Diabetes; 2003 May; 111(3):121-4. PubMed ID: 12784183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Macronutrients, fat mass, fatty acid flux and insulin sensitivity].
    Ziegler O; Quilliot D; Guerci B; Drouin P
    Diabetes Metab; 2001 Apr; 27(2 Pt 2):261-70. PubMed ID: 11452220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free fatty acids and insulin resistance.
    Delarue J; Magnan C
    Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):142-8. PubMed ID: 17285001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in postprandial ketone bodies in normolipidemic subjects and in untreated patients with familial combined hyperlipidemia.
    Halkes CJ; van Dijk H; Verseyden C; de Jaegere PP; Plokker HW; Meijssen S; Erkelens DW; Cabezas MC
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1875-80. PubMed ID: 12933534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acids and insulin resistance in muscle and liver.
    Kovacs P; Stumvoll M
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):625-35. PubMed ID: 16311221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-dependent insulin modulation of oscillatory lipolysis in perifused rat adipocytes.
    Getty-Kaushik L; Richard AM; Corkey BE
    Obes Res; 2005 Dec; 13(12):2058-65. PubMed ID: 16421338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans.
    Rigazio S; Lehto HR; Tuunanen H; Någren K; Kankaanpaa M; Simi C; Borra R; Naum AG; Parkkola R; Knuuti J; Nuutila P; Iozzo P
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E413-9. PubMed ID: 18505832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage.
    Raz I; Eldor R; Cernea S; Shafrir E
    Diabetes Metab Res Rev; 2005; 21(1):3-14. PubMed ID: 15386813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct free fatty acid uptake into human adipocytes in vivo: relation to body fat distribution.
    Shadid S; Koutsari C; Jensen MD
    Diabetes; 2007 May; 56(5):1369-75. PubMed ID: 17287467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid metabolism and vascular disease.
    Semenkovich CF
    Trends Cardiovasc Med; 2004 Feb; 14(2):72-6. PubMed ID: 15030793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
    Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V; Chinetti G; Fruchart JC; Staels B
    J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta.
    Lam TK; Yoshii H; Haber CA; Bogdanovic E; Lam L; Fantus IG; Giacca A
    Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E682-91. PubMed ID: 12217885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of triglyceride-rich lipoproteins to plasma free fatty acids.
    Miles JM; Nelson RH
    Horm Metab Res; 2007 Oct; 39(10):726-9. PubMed ID: 17952834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo.
    Park E; Wong V; Guan X; Oprescu AI; Giacca A
    J Endocrinol; 2007 Nov; 195(2):323-31. PubMed ID: 17951543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin sensitivity indices of glucose and free fatty acid metabolism in obese children and adolescents in relation to serum lipids.
    Reinehr T; Kiess W; Andler W
    Metabolism; 2005 Mar; 54(3):397-402. PubMed ID: 15736120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.